AMD after cataract surgery unclear

Article

The answer may be found in the masking effects of catract upon pre-existing disease

The association between cataract surgery and progression of age-related macular degeneration (AMD) still is unclear, said Dr Neil M. Bressler.

In light of this uncertainty, ophthalmologists can consider cataract surgery even in patients with AMD if the cataract affects vision and the patient's quality of life, Dr Bressler added.

Globally, cataracts are one of the leading causes of blindness, and according to the World Health Organization (WHO) "age-related cataract are responsible for 48% of world blindness." Additionally, WHO reports that in its 2010 estimates AMD is in the top three causes of blindness.1

Yet, there are questions as to the association between cataract surgery and the progression of AMD. According to Dr Bressler, clinical evidence shows no increase in risk for progression to advanced AMD after cataract surgery.

"If you think the cataract is visually significant to a patient, you should consider removing the cataract," he said. "There is no clear evidence that AMD eyes are at clinically important greater risk for progression to advanced AMD following cataract surgery."

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
© 2025 MJH Life Sciences

All rights reserved.